Analysis of publicly available PCa datasets confirmed that METTL3 copy number and mRNA expression is altered frequently in PCa patients, including in advanced tumour types, supporting a role for METTL3 in PCa progression. This evidence concerns the gene METTL3 and posterior cortical atrophy.